MDL-29311

N/A

Report date: 2023/02/15 14:12:41
NME

Base Information

Drug NameMDL-29311
Drug Alias NameMDL-29311
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxygen radical scavengers
TargetsNot applicable
Therapy Area/IndicationsHyperlipidemiasDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A